Clinical Trials Directory

Trials / Sponsors / Prescient Therapeutics, Ltd.

Prescient Therapeutics, Ltd.

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
CTCL
Phase 22025-03-28
CompletedPhase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
Advanced Cancer, PTCL
Phase 12019-09-01
CompletedA Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
Acute Leukemia
Phase 1 / Phase 22016-12-09
TerminatedPTX-200 and Carboplatin in Ovarian Cancer
Ovarian Cancer
Phase 1 / Phase 22014-09-01
TerminatedPTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Br
Breast Adenocarcinoma, Estrogen Receptor Positive, HER2/Neu Negative
Phase 1 / Phase 22012-01-01
CompletedTriciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies
Hematologic Malignancies, Leukemia
Phase 12006-08-01
CompletedPhase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer
Cancer
Phase 12006-04-01